−£19k
vs Oct 2024Active12065717Private limited companyCambridge
AMPKINE LIMITED
Significant control: Elements Squared Limited (25–50%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Ampkine Limited: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
Coming soon · product and service lists
What does Ampkine Limited sell?
Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.
One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01
Summary
AMPKINE LIMITED is an active private limited company (company number 12065717) incorporated on 24 June 2019, registered in Cambridge. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest small accounts cover the period ending 31 October 2025, showing net assets of −£19k and cash of £3,157, with 2 employees on average. Net assets fell 526% on the prior period (−£3,100).
Peer position · net assets
By net assets it sits in the bottom quarter of 196 comparable companies in Cambridge (median £15k, upper quartile £347k).
02
Ownership and control
- Elements Squared Limited
- owns 25–50% of shares
- holds 25–50% of voting rights
- Dr David John Grainger
- owns 75–100% of shares
- holds 75–100% of voting rights
- can appoint or remove directors
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
03
Key dates
- Incorporated
- 24 June 20197 yrs ago
- Next accounts due
- 31 July 2027in 278 days
- Confirmation statement due
- 8 July 2027in 255 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
04
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Total Exemption Full
- Size band
- MicroCompanies Act thresholds
05
Financials
£3,157
+1342%vs Oct 2024Not reported
2
vs Oct 2024| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 October 2025 | −£19k | £3,157 | £9,325 | — | — | −£48k | 2 |
| 31 October 2024 | −£3,100 | £219 | £0 | — | — | — | 0 |
Cash per employee£1,578Cash ÷ average employees
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
06
Filing and accounts signals
- Net assets below zeroNet assets £-19,408 at 31 October 2025
- Net assets down 25% or more on the prior period-526.1% vs prior period
- Incorporated five or more years agoIncorporated 24 June 2019
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
07
Timeline
- Next accounts duein 278 days
- Confirmation statement duein 255 days
- Accounts period endNet liabilities £19k · small accounts
- Accounts period endNet liabilities £3,100 · small accounts
- Incorporated
08
Similar companies in Cambridge
- AGILE BIOMEDICAL CONSULTANTS LIMITEDCambridge · inc. Jul 2019
- DISCOVERY PHARMA CONSULTING (UK) LTDCambridge · inc. Jul 2019
- DRISHTI DISCOVERIES LTD.Cambridge · inc. May 2019
- LYCOTEC FOOD LIMITEDCambridge · inc. Aug 2019
- TRX BIOSCIENCES LIMITEDCambridge · inc. May 2019
- INNVO-GEN LIMITEDCambridge · inc. Aug 2019
All companies incorporated on 24 June 2019 · in Jun 2019.
09
Reminders for AMPKINE LIMITED
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.